CYP4F3 | Cytochrome P450, family 4, subfamily F, polypeptide 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
DPPA4 | Developmental pluripotency associated 4 | | | | | | Tissue enhanced |
DTL | Denticleless E3 ubiquitin protein ligase homolog (Drosophila) | | | | | | Tissue enhanced |
E2F1 | E2F transcription factor 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ELL3 | Elongation factor RNA polymerase II-like 3 | | | | | | Tissue enhanced |
EN1 | Engrailed homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
EXO1 | Exonuclease 1 | | | | | | Tissue enhanced |
FBXO5 | F-box protein 5 | | | | | | Tissue enhanced |
FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) | CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FCRL1 | Fc receptor-like 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FYB | FYN binding protein | | | | | | Tissue enhanced |
GAL | Galanin/GMAP prepropeptide | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GBP5 | Guanylate binding protein 5 | | | | | | Tissue enhanced |
GFI1 | Growth factor independent 1 transcription repressor | Disease related genes Transcription factors
| | | | | Tissue enhanced |
GLT1D1 | Glycosyltransferase 1 domain containing 1 | | | | | | Tissue enhanced |
GNLY | Granulysin | Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
GP1BA | Glycoprotein Ib (platelet), alpha polypeptide | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GP9 | Glycoprotein IX (platelet) | CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
GPR182 | G protein-coupled receptor 182 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GRAP2 | GRB2-related adaptor protein 2 | Plasma proteins
| | | | | Tissue enhanced |
GSDMC | Gasdermin C | | | | | | Tissue enhanced |
GZMB | Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HIST1H2AB | Histone cluster 1, H2ab | | | | | | Tissue enhanced |
HIST1H2BI | Histone cluster 1, H2bi | Plasma proteins
| | | | | Tissue enhanced |
HIST1H2BM | Histone cluster 1, H2bm | | | | | | Tissue enhanced |
HIST1H2BO | Histone cluster 1, H2bo | | | | | | Tissue enhanced |
HIST1H3A | Histone cluster 1, H3a | | | | | | Tissue enhanced |
HIST1H3F | Histone cluster 1, H3f | | | | | | Tissue enhanced |
HIST1H3H | Histone cluster 1, H3h | | | | | | Tissue enhanced |
HJURP | Holliday junction recognition protein | | | | | | Tissue enhanced |
HK3 | Hexokinase 3 (white cell) | Enzymes Plasma proteins
| | | | | Tissue enhanced |
ICOS | Inducible T-cell co-stimulator | CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
IGSF21 | Immunoglobin superfamily, member 21 | Predicted secreted proteins
| | | | | Tissue enhanced |
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | Cancer-related genes Disease related genes Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
IKZF3 | IKAROS family zinc finger 3 (Aiolos) | Transcription factors
| | | | | Tissue enhanced |
IL18RAP | Interleukin 18 receptor accessory protein | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL2RA | Interleukin 2 receptor, alpha | Cancer-related genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
IL2RB | Interleukin 2 receptor, beta | Cancer-related genes CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL2RG | Interleukin 2 receptor, gamma | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
IL4I1 | Interleukin 4 induced 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
IL7R | Interleukin 7 receptor | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IRF8 | Interferon regulatory factor 8 | Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ITGA2B | Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ITGAX | Integrin, alpha X (complement component 3 receptor 4 subunit) | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
KAZN | Kazrin, periplakin interacting protein | | | | | | Tissue enhanced |
KIAA0101 | KIAA0101 | Mitochondrial proteins
| | | | | Tissue enhanced |
KIAA0226L | KIAA0226-like | | | | | | Tissue enhanced |
KIF21B | Kinesin family member 21B | Plasma proteins
| | | | | Tissue enhanced |
KLHL15 | Kelch-like family member 15 | | | | | | Tissue enhanced |
KLRC3 | Killer cell lectin-like receptor subfamily C, member 3 | Predicted membrane proteins
| | | | | Tissue enhanced |